XML 28 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation Stock Options (Details) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2014
Oct. 31, 2013
Apr. 30, 2014
Stock options (including SARs)
Jan. 31, 2014
Stock options (including SARs)
Oct. 31, 2013
Stock options (including SARs)
Apr. 30, 2014
Stock options (including SARs)
Apr. 30, 2014
Stock Options
Apr. 30, 2013
Stock Options
Apr. 30, 2014
Stock Options
Apr. 30, 2013
Stock Options
Apr. 30, 2014
SARs
Apr. 30, 2013
SARs
Apr. 30, 2014
SARs
Apr. 30, 2013
SARs
Awards (in Shares)                            
Outstanding, Beginning Balance     2,744,445 2,877,620 3,047,910 3,047,910                
Granted     8,460 11,000 247,000           0 0 0 0
Expired/canceled     (15,220) (52,800) (413,240)                  
Exercised     (124,505) (91,375) (4,050)           0 0 0 0
Outstanding, Ending Balance     2,613,180 2,744,445 2,877,620 2,613,180                
Exercisable, Ending Balance     1,281,048     1,281,048                
Vested and Expected to Vest, Ending Balance     2,554,057     2,554,057                
Weighted Average Exercise Price                            
Outstanding, Beginning Balance     $ 27.48 $ 27.46 $ 29.94 $ 29.94                
Granted     $ 30.12 $ 31.29 $ 27.23                  
Expired/canceled     $ 30.72 $ 27.80 $ 45.66                  
Exercised     $ 27.61 $ 27.14 $ 19.54                  
Outstanding, Ending Balance     $ 27.46 $ 27.48 $ 27.46 $ 27.46                
Exercisable, Ending Balance     $ 27.11     $ 27.11                
Vested and Expected to Vest, Ending Balance     $ 27.45     $ 27.45                
Weighted Average Remaining Contractual Term (Years)                            
Outstanding, Ending Balance           5 years 5 months 20 days                
Exercisable, Ending Balance           2 years 11 months 27 days                
Vested And Expected To Vest, Ending Balance           5 years 5 months 2 days                
Aggregate Intrinsic Value                            
Outstanding, Ending Balance     $ 11,220,000     $ 11,220,000                
Exercisable, Ending Balance     5,964,000     5,964,000                
Vested and Expected to Vest, Ending Balance     10,998,000     10,998,000                
Additional Disclosures                            
Exercise price, lower range limit           $ 13.19                
Exercise price, upper range limit           $ 35.79                
Total intrinsic value of stock-based awards exercised             $ 533,000 $ 149,000 $ 965,000 $ 413,000        
Contractual term (in years)                 10 years 10 years        
Vesting period (in years)                 5 years 5 years        
Per share weighted average grant date fair value of stock based awards granted             $ 5.91   $ 5.51 $ 5.46        
Targeted annual dividend per share $ 1.20 $ 1.10                        
Fair Value Assumptions                            
Expected dividend yield             3.98%   4.03% 4.29%        
Expected volatility             32.00%   32.83% 37.00%        
Risk-free interest rate             1.49%   1.39% 0.61%        
Expected life (years)             5 years 3 months 22 days   5 years 5 months 5 days 5 years 3 months 22 days